Crick — Clinical Intelligence Platform

Not applicableStudy completedNCT02239887

What this trial is testing

Coherex WAVECREST I Left Atrial Appendage Occlusion Study

Who this might be right for

Non-valvular Paroxysmal, Persistent, or Permanent Atrial FibrillationLAA Anatomy Amenable to Treatment by Percutaneous TechniqueAnticoagulation Indication for Potential Thrombus Formation in the Left Atrium

Coherex Medical 155

Results for “Oral Anticoagulation”

Coherex WAVECREST I Left Atrial Appendage Occlusion Study

START-Register: Survey on Anticoagulated Patients Register

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

Comparison of Outcomes After Left Atrial Appendage Closure or Oral Anticoagulation in Patients With Atrial Fibrillation

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation

A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study)

Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke

Responding to AF: Pill-in-Pocket Anticoagulation Guided by Automated Monitoring and Alerts

Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study.

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.

Safety of Oral Anticoagulants Registry

DIrect Oral Anticoagulation and Bioprothesis Aortic Valve

Efficacy of Direct Oral Anticoagulants as a Prophylactic Anticoagulation of Catheter Induced Thrombosis

Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department